AEMS

Name

AEMS

Legal name

AEMS Corp.

Website

https://aemscorp.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Specialty Formulation Engineering Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)

Keywords

• Viscosity reduction solutions
• Formulation engineering services
• Biologics formulation development
• Sprayable coating formulation
• High-throughput screening services

Headquarters

HQ city

Livermore

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Formulation Development Services: AEMS provides specialized formulation engineering services where they design and execute experiments using proprietary methods to solve viscosity problems for clients. Services include engineering formulations from the ground up or refining existing formulations. Revenue appears to be project-based professional services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

AEMS designs and executes formulation experiments using proprietary methods, patented technologies, and an automated facility featuring high-throughput and microscale capabilities (20 uL per experiment, 600+ experiments weekly) to solve viscosity problems for clients in next-generation pharmaceuticals, antimicrobial coatings, and food preservation. The company either engineers formulations from the ground up or refines existing ones, drawing on a living library of excipient interactions to uncover synergistic molecule combinations that conventional trial-and-error approaches miss, and offers a complementary proprietary sprayable antimicrobial edible coating (ADM).

Product overview

AEMS Corp offers a viscosity reduction platform and formulation engineering services focused on next-generation pharmaceuticals. The core platform enables high-throughput, microscale experiments (as low as 20 µL per experiment) using proprietary methods and patented technologies to uncover synergistic molecule interactions that reduce viscosity. The platform is complemented by ADM™ (Agent Delivery Matrix), an antimicrobial sprayable coating product for food safety applications, and is grounded in RAMETRIC technology originally developed for stabilizing and delivering antibacterial agents.

Differentiator

Problem solved

Functional benefit

Brands

• ADM (Agent Delivery Matrix): An antimicrobial and edible sprayable coating developed by AEMS to provide safe and effective pathogen protection in food applications.
• RAMETRIC

Products and services

• Viscosity Reduction Formulation Engineering Services Project-based formulation engineering services in which AEMS designs and runs experiments using proprietary viscosity reduction methods, an automated 600+ experiments/week pipeline, and 20 uL microscale capability to optimize or de-risk client formulations for injectable biologics, siRNA therapeutics, sprayable coatings, and food preservatives; delivered as custom engagements to pharmaceutical, biotech, coatings, and food industry clients.
• ADM (Agent Delivery Matrix) Proprietary antimicrobial, edible sprayable coating developed by AEMS to deliver safe and effective pathogen protection in food applications using AEMS-formulated chemistries tuned for optimal spray flow and uniform coverage. Aimed at food and agriculture customers seeking edible antimicrobial coating solutions.
• RAMETRIC Materials Proprietary rigid amorphous metal-rich (RAMETRIC) materials that stabilize and deliver antibacterial silver ions, representing AEMS's foundational molecular platform and enabling next-generation antimicrobial coatings, sprays, and related delivery systems for life-science and food-safety applications.

Quantifiable outcome

• 600+ experiments per week using automated pipeline
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Colorado State University (CSU) SpurcoreStrategic or Co-development Partner · 1 September 2023AEMS became the first business tenant at CSU Spur campus in Denver, establishing their headquarters and laboratory facilities at this innovation hub. The partnership provides access to university research resources and collaborative opportunities.
• Colorado State University (CSU) VenturescoreStrategic or Co-development PartnerAEMS leadership has participated in CSU Ventures Launchpad entrepreneurship programs. The company has connections to CSU spinouts including Revalix Labs (nanomaterials) where Alex Hendricks serves on the board.
• Revalix LabsminorStrategic or Co-development PartnerAlex Hendricks, CIO of AEMS, serves on the board of Revalix Labs, a CSU nanomaterials spinout, representing a strategic connection in the nanomaterials sector.
• I-Corps ProgramminorStrategic or Co-development PartnerAEMS leadership has commercialization experience from the I-Corps entrepreneurship program, which provides customer discovery and lean startup methodology training.
• DOE National Lab Entrepreneurship ProgramsminorStrategic or Co-development PartnerCompany leadership has experience from Department of Energy national laboratory entrepreneurship programs, providing access to national research infrastructure.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Apeel Sciences: Developer of edible plant-derived coatings that slow water loss and oxidation in fresh produce, directly comparable to AEMS's ADM antimicrobial edible sprayable coating for food pathogen protection.
• Mori: Develops edible protein-based coatings to extend shelf life of fresh food; closest direct peer in the edible food coatings space alongside AEMS's ADM offering.
• Vibalogics: CDMO focused on viral vectors, vaccines, and complex biologics with difficult formulation profiles; comparable service model and customer base to AEMS in pharma formulation.
• Carbogen Amcis: Specialty pharmaceutical services firm offering API development and formulation support; closely comparable CRO/CDMO position serving pharmaceutical customers facing complex formulation challenges.
• Arranta Bio: CDMO specializing in microbiome and complex biologics with difficult viscosity and formulation challenges; comparable in serving pharma customers with high-concentration biologics programs.
• Halo Pharma (Bora Pharmaceuticals): Specialty pharmaceutical CDMO offering formulation development and manufacturing services; comparable CRO/CDMO for pharmaceutical customers needing custom formulation work.

Broad incumbents

• Catalent: Large global CDMO with deep biologics formulation and softgel/injectable capabilities; broad incumbent that overlaps with AEMS's biologics viscosity reduction platform.
• Lonza: World's largest CDMO with extensive biologics, cell and gene therapy, and formulation services; broad incumbent in the same pharmaceutical services space as AEMS.
• WuXi STA (WuXi AppTec): Global CDMO offering API and formulation services for both small molecules and biologics; broad incumbent providing adjacent/overlapping capabilities to AEMS's formulation services.

Emerging players

• Meta Materials: Develops novel functional materials and metamaterial platforms; comparable to AEMS's RAMETRIC materials discovery as an emerging player pioneering advanced material breakthroughs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/aemscorp

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds6 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AEMS